Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Inoviq.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: INOVIQ says its breast cancer technology beats currently available tests
News
Top 10 at 10: These ASX stocks are building up a head of steam in early trade
Health & Biotech
ASX Health Stocks: Inoviq and Doctor Care Anywhere surge over 20pc; CSL welcomes new CEO
News
Top 10 at 10: ASX stocks rocket on positive clinical studies, shallow gold, and high grade niobium
Health & Biotech
ASX Health Stocks: Argenica steps up dose in Phase 1 trial; Medlab gets blessing from UK regulator
Health & Biotech
Lots of milestones expected from INOVIQ in 2023 as it aims to commercialise cancer diagnostics products in the US
News
ASX Quarterlies: Smiles all around as cybersec blossoms, biotechs well-funded to focus on trials
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
INOVIQ is carving itself a healthy share of the multi-billion dollar medical diagnostics market
Health & Biotech
ASX Health Stocks: INOVIQ reports good study results; Mayne Pharma launches unique oral contraceptive
Health & Biotech
ASX Health Stocks: Inoviq pockets another US patent, its second in a month
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Health & Biotech
ASX Health Stocks: UK FSA welcomes Cann’s CBD capsules onto its approved list
News